US proposed investment rules could hinder Chinese biotech expansion. Direct investment and joint ventures face stricter limits. Drug licensing agreements remain unaffected under current rules.
https://www.scmp.com/business/article/3372151/could-new-us-investment-curbs-complicate-chinas-biotech-licensing-surge
Image:
#biotech #investment #china #us
https://www.scmp.com/business/article/3372151/could-new-us-investment-curbs-complicate-chinas-biotech-licensing-surge
Image:
#biotech #investment #china #us
Views: 7
Categories: News & Updates [c3], Projects & Resources [c5]